Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Globus Medical, Inc. Class A Common Stock (NY: GMED )

90.80 +0.33 (+0.36%)
Official Closing Price Updated: 7:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,863,940
Open 90.62
Bid (Size) 90.00 (1)
Ask (Size) 92.54 (1)
Prev. Close 90.47
Today's Range 89.34 - 91.04
52wk Range 49.33 - 91.44
Shares Outstanding 136,167,342
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stryker Had A Good Year Last Year; Here's How It's Looking For 2025
Reflecting its strong growth, on Monday the Relative Strength (RS) Rating for Stryker stock got an upgrade from 70 to 74. 
Via Investor's Business Daily
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results
From Globus Medical
Via GlobeNewswire

Performance

YTD
+10.96%
+10.96%
1 Month
+9.27%
+9.27%
3 Month
+23.55%
+23.55%
6 Month
+23.66%
+23.66%
1 Year
+62.06%
+62.06%

More News

Read More
The Law Offices of Frank R. Cruz Continues Its Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Inspire Medical's Sleep Innovations Driving Big Gains
Via Investor's Business Daily
Price Over Earnings Overview: Globus Medical
Via Benzinga
Why GLOBUS MEDICAL INC - A (NYSE:GMED) qualifies as a high growth stock.
Via Chartmill
16 Analysts Have This To Say About Globus Medical
Via Benzinga
Lantheus Stock Doubled In A Year Amid Wide Use Of Its AI-Enabled Medical Devices
Via Investor's Business Daily
Inari Medical Stock Gets RS Rating Upgrade
Via Investor's Business Daily
Should you consider GLOBUS MEDICAL INC - A (NYSE:GMED) for high growth investing?
Via Chartmill
Novocure Stock Earns 96 RS Rating
Via Investor's Business Daily
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Via Benzinga
Evaluating Globus Medical: Insights From 11 Financial Analysts
Via Benzinga
What 7 Analyst Ratings Have To Say About Globus Medical
Via Benzinga
The Analyst Verdict: Globus Medical In The Eyes Of 7 Experts
Via Benzinga
Globus Medical Launches ExcelsiusHub™ Navigation System
From Globus Medical
Via GlobeNewswire
Despite its growth, NYSE:GMED remains within the realm of affordability.
Via Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
CVS Health, Johnson Controls And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
Globus Medical (GMED) Q3 2024 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
NYSE:GMED is showing good growth, while it is not too expensive.
Via Chartmill
Globus Medical Reports Third Quarter 2024 Results
From Globus Medical
Via GlobeNewswire
Globus Medical to Participate in Orthopedic Trauma Association Annual Meeting
From Globus Medical
Via GlobeNewswire
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
From Globus Medical
Via GlobeNewswire
Globus Medical Launches the Next Wave of Orthopedic Trauma Solutions
From Globus Medical
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.